Frazier Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Frazier Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,082,789	Closed	-$57.4M	–	42
2021 Q2	$57.4M	Sell	2,082,789 -100,000	-5%	-$1.97M	5.29%	5
2021 Q1	$36M	Hold	2,182,789	–	–	2.89%	9
2020 Q4	$40.2M	Hold	2,182,789	–	–	3.1%	10
2020 Q3	$29.7M	Hold	2,182,789	–	–	2.67%	10
2020 Q2	$39.1M	Hold	2,182,789	–	–	3.43%	7
2020 Q1	$21.8M	Hold	2,182,789	–	–	2.47%	8
2019 Q4	$17.8M	Hold	2,182,789	–	–	2.98%	8
2019 Q3	$21.6M	Buy	2,182,789 +500,000	+30%	+$4.72M	6.76%	6
2019 Q2	$21.3M	Buy	+1,682,789	New	+$17.7M	5.45%	6

Frazier Management's TBIO Position: Q3 2021 in Review

Frazier Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 2,082,789 shares — an estimated $57.4M sold.

Frazier Management first reported a position in TBIO in Q2 2019 and held it in 9 quarters. The position peaked at $57.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Frazier Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Frazier Management sold 2,082,789 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $57.4M.
Frazier Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
Frazier Management's Translate Bio, Inc. Common Stock position peaked at $57.4M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Frazier Management's 13F filing for Q3 2021, filed 12 Nov 2021.